Skip to main content

Table 1 Patient characteristics

From: Intestinal dysbiosis is common in systemic sclerosis and associated with gastrointestinal and extraintestinal features of disease

 

n

(%)

Systemic sclerosis subtype

  limited cutaneous SSc

77

(78)

  diffuse cutaneous SSc

21

(22)

Autoantibodies

  ANA-positive

87

(89)

  ACA-positive

33

(34)

  ARA-positive

10

(10)

  ATA-positive

11

(11)

Smoking

  smoker

11

(11)

  ex-smoker

43

(44)

  non-smoker

44

(45)

Telangiectasias

39

(40)

Pulmonary arterial hypertensiona

13

(13)

Pitting scars, current

23

(23)

Lung fibrosisb

35

(36)

Pathological cineradiography

82

(84)

Regular PPI usage

78

(80)

Immunosuppressive therapy

  

  mycophenolate mofetil

23

(23)

  methotrexate

5

(5)

  azathioprine

10

(10)

  no immunosuppressive therapy

60

(61)

 

median

interquartile range

Modified Rodnan skin score

  limited cutaneous

2

(0, 4)

  diffuse cutaneous

10

(4, 22)

Disease duration, yearsc

6

(2, 16)

Prednisolone, daily intake (mg)

0

(0, 4)

  1. ANA anti-nuclear antibodies, ACA anti-centrome antibodies, ARA anti-RNA polymerase III antibodies, ATA anti-topoisomerase1 antibodies, PPI proton pump inhibitor
  2. aAs determined by right heart catheterisation
  3. bAs determined on high-resolution computed tomography
  4. cYears since first non-Raynaud’s phenomena symptom
Back to article page

Arthritis Research & Therapy

ISSN: 1478-6362

Contact us